Page last updated: 2024-11-02

pantoprazole and Sepsis

pantoprazole has been researched along with Sepsis in 1 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Terzi Coelho, CB1
Dragosavac, D1
Coelho Neto, JS1
Montes, CG1
Guerrazzi, F1
Andreollo, NA1

Trials

1 trial available for pantoprazole and Sepsis

ArticleYear
Ranitidine is unable to maintain gastric pH levels above 4 in septic patients.
    Journal of critical care, 2009, Volume: 24, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; APACHE; Female; Gastric Acid; His

2009